Posts tagged Synergy Pharmaceuticals Inc


Here’s Why H.C. Wainwright Just Cut the Price Target for Synergy Pharmaceuticals Inc (SGYP) by 50%

Ram Selvaraju slashes his target to $8 on slower Trulance ramp.

Read more

World’s Smartest Billionaire Jim Simons Pulls the Trigger on Array Biopharma Inc (ARRY) and Valeant Pharmaceuticals Intl Inc (VRX), Exits Synergy Pharmaceuticals Inc (SGYP)

Three key biopharma trades from the highly-successful $78 billion Renaissance fund

Read more

Cantor Offers Bullish Forecast on Synergy Pharmaceuticals Inc (SGYP) Following 2Q Earnings Showcase

Investors to get a better viewpoint of Trulance during today’s call, says analyst.

Read more

Synergy Pharmaceuticals Inc (SGYP) Has Encouraging Sustainability Through 2019 Thanks to $300 Million Debt Financing

Synergy protects “financial health” without the sacrifice of extra pressure on share price, says Canaccord.

Read more

Kingdon Capital Sells Off 3 Pharma Stocks: Otonomy Inc (OTIC), Synergy Pharmaceuticals Inc (SGYP), Antares Pharma Inc (ATRS)

Hedge Fund Guru Mark Kingdon Isn’t Taking Any Risks with OTIC, SGYP, ATRS

Read more

Analysts Shine More Light on These 2 Biotech Stocks: Synergy Pharmaceuticals Inc and Gilead Sciences, Inc.

Synergy Still Showcases Promising Commercial Trajectory in CIC Rodman & Renshaw analyst Ram Selvaraju still …

Read more

Synergy Pharmaceuticals Inc (SGYP) Trulance Market Adoption Pattern Looks Positive: Canaccord

Synergy Pharmaceuticals Inc (NASDAQ:SGYP) stock is on the downward spiral today, to the harsh, discordant …

Read more

Synergy Pharmaceuticals Inc’s (SGYP) Posts 2Q:17 Trulance U.S. Net Sales of $2.3M

Synergy Pharmaceuticals Inc (NASDAQ:SGYP) reported its financial results and business update for the three months …

Read more

Synergy Pharmaceuticals Inc (SGYP) Trulance Has Solid Niche Market Potential Even Amid Express Scripts Setback

Synergy Pharmaceuticals Inc (NASDAQ:SGYP) shares were on a 4% cave yesterday on the heels of …

Read more

Express Scripts Stiff-Arms Synergy Pharmaceuticals Inc’s (SGYP) Trulance; Canaccord Analyst Comments

Express Scripts, a company that controls about 40 percent of the pharmacy benefit market, will …

Read more